Bottle of Lies
The Inside Story of the Generic Drug Boom
No se pudo agregar al carrito
Add to Cart failed.
Error al Agregar a Lista de Deseos.
Error al eliminar de la lista de deseos.
Error al añadir a tu biblioteca
Error al seguir el podcast
Error al dejar de seguir el podcast
Obtén 3 meses por US$0.99 al mes
Exclusivo para miembros Prime: ¿Nuevo en Audible? Obtén 2 audiolibros gratis con tu prueba.
Compra ahora por $7.99
-
Narrado por:
-
Katherine Eban
-
De:
-
Katherine Eban
From an award-winning Fortune reporter, an explosive narrative investigation of the generic drug boom that reveals the life-threatening dangers posed by globalization—The Jungle for pharmaceuticals
The widespread use of generic drugs has been hailed as one of the most important public health developments of the twentieth century. Today, almost 90 percent of our pharmaceutical market is comprised of generics, the majority of which are manufactured overseas. We have been reassured by our pharmacists, our doctors, and our regulators that the generic and brand-name drugs are identical, generics just cheaper. But is this really true?
Katherine Eban’s Bottle of Lies exposes the widespread deceit behind generic drug manufacturing—creating terrifying risks for global health. Drawing on exclusive accounts from whistleblowers, inspectors, and regulators, as well as thousands of pages of confidential internal FDA documents, Eban reveals an industry where fraud is rampant, companies falsify data, and executives circumvent almost every principle of safe manufacturing to minimize cost and maximize profit. Meanwhile, patients unwittingly consume adulterated medicine with unpredictable and even life-threatening effects.
The story of generic drugs is truly global: it connects middle America to sub-Saharan Africa, China, India, and Brazil, and encompasses every market banking on the promise of a low-cost cure. Given that tens of millions of patients take drugs of dubious quality approved with fake data, the generics industry is the ultimate litmus test of globalization: what is the risk of moving drug manufacturing offshore, and is it worth the savings?
An investigation with international sweep, exotic settings, molecular mayhem, and big money at its core, Bottle of Lies reveals how the world’s greatest public-health innovation has become one of its most astonishing swindles.
Los oyentes también disfrutaron:
Las personas que vieron esto también vieron:
There are several heroes in her book who go out of their way to try to expose those shoddy and unsafe drugs. It is particularly scary that our own FDA apparently, in many cases, thwarts honest FDA drug inspectors who criticize and issue stern warnings about dishonest companies. It appears that the FDA is more interested in insuring an adequate supply of generics because of congressional pressure, than insuring the safety of those drugs imported from overseas. I wonder just how many FDA officials are willing to take drugs made by these firms or allowing family members to take these drugs if this book is true?
A frightening book!
Se ha producido un error. Vuelve a intentarlo dentro de unos minutos.
Scariest book ever
Se ha producido un error. Vuelve a intentarlo dentro de unos minutos.
FDA bought and paid for
Se ha producido un error. Vuelve a intentarlo dentro de unos minutos.
A must read!
Se ha producido un error. Vuelve a intentarlo dentro de unos minutos.
Highly recommended if you want to know more about the pharmaceutical industry
Se ha producido un error. Vuelve a intentarlo dentro de unos minutos.